Submission Details
| 510(k) Number | K131549 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 29, 2013 |
| Decision Date | July 26, 2013 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K131549 is an FDA 510(k) clearance for the CHEMOLOCK, CHEMOLOCK PORT, a Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System (Class II — Special Controls, product code ONB), submitted by Icu Medical, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on July 26, 2013, 58 days after receiving the submission on May 29, 2013. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K131549 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 29, 2013 |
| Decision Date | July 26, 2013 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | ONB — Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |
| Definition | Reconstitute And Transfer Antineoplastic And Other Hazardous Drugs In Healthcare Setting Indicated To Reduce Exposure Of Healthcare Personnel To Chemotherapy Agents In Healthcare Setting. |